First Plasma Collection Centers Certified in Hungary

Description

First Plasma Collection Centers CertifiedFirst Plasma Collection Centers Certified in Hungary PR Newswire ANNAPOLIS, Maryland, April 14, 2014 - Plazmaferezis Allomas Kft ("PFÁ") Achieves International Certification The Plasma Protein Therapeutics Association (PPTA) has awarded

Informations

• Publié par: plasma-protein-therapeutics-association-ppta
• Publié le: 14 avril 2014
• Nombre de lectures: 1
• Langue: English

Extrait

First Plasma Collection Centers Certified in Hungary

PR Newswire

ANNAPOLIS, Maryland, April 14, 2014

- Plazmaferezis Allomas Kft ("PFÁ") Achieves International Certification

The Plasma Protein Therapeutics Association (PPTA) has awarded Plazmaferezis Allomas Kft (PFÁ), a member operating within the Kedrion group of companies, with International Quality Plasma Program (IQPP) certification for its plasma collection centers in Hungary; two in Budapest and one in Debrecen. The three centers are the first in the country to become IQPP certified.

Certification is obtained via a rigorous inspection by an independent third party, and demonstrated compliance with voluntary standards that ensure the highest level of quality and safety of human source plasma.

Gabi Komlodi, the Managing Director, said, "Considering that the plasma collected ultimately serves the health and well-being of Hungarian patients, as part of Kedrion Group, we set the bar high and therefore wanted to measure up to the IQPP standards. Whatever we do, we want to do it right."

People worldwide depend on lifesaving plasma protein therapies to treat bleeding and immune disorders, other diseases and injury. PFÁ's mission has been to continuously improve with a focus on safety and quality from the donor to the patient.

Joshua Penrod, Vice President, PPTA Source said, "We congratulate Plazmaferezis Allomas Kft on obtaining this mark of distinction which demonstrates its commitment to plasma quality and safety." 

About PPTA 
The Plasma Protein Therapeutics Association (PPTA), a global industry trade association, represents the private sector manufacturers of plasma-derived and recombinant analog therapies, collectively known as plasma protein therapies and the collectors of source plasma used for fractionation. These therapies are used by millions of people worldwide to treat a variety of diseases and serious medical conditions. PPTA also administers standards and programs that help ensure the quality and safety of plasma protein therapies, donors and patients.

About Plazmaferezis Allomas Kft ("PFÁ")

PFÁ is a member of Kedrion Group and is specialized in the collection of high-quality plasma which is processed into life-saving plasma-derived therapies at the group's biopharmaceutical plants of Human Bioplazma (Hungary) and Kedrion SpA (Italy). Owned by Human Bioplazma, PFÁ is based in Godollo (Budapest, Hungary) and has three state-of-the-art collection centers, two in Budapest and one in Debrecen.

In Italy, Kedrion is the partner of the National Health Service for the achievement of nationwide self-sufficiency in plasma derivatives. With its headquarters in Italy, companies in Europe, Mexico and the United States, Kedrion distributes its plasma protein therapies in 90 countries worldwide. For more information about Kedrion, please visit www.kedrion.com